The serologic markers of the therapeutic response of chronic necrotizing pulmonary aspergillosis (CNPA) are rarely reported. Here, we describe the changes in galactomannan (GM) antigenemia in a patient receiving oral voriconazole for CNPA, in whom a resolution of GM antigenemia to a normal level was associated with clinical improvements. The serum GM index can be an adjunctive tool for the diagnosis and monitoring of the therapeutic response of CNPA.
|Number of pages||3|
|Journal||Diagnostic Microbiology and Infectious Disease|
|Publication status||Published - 2011 Aug 1|
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases